CA3118317C - Administration a l'homme de butyrate, de beta-hydroxybutyrate, de cannabidiol et de composes apparentes - Google Patents

Administration a l'homme de butyrate, de beta-hydroxybutyrate, de cannabidiol et de composes apparentes

Info

Publication number
CA3118317C
CA3118317C CA3118317A CA3118317A CA3118317C CA 3118317 C CA3118317 C CA 3118317C CA 3118317 A CA3118317 A CA 3118317A CA 3118317 A CA3118317 A CA 3118317A CA 3118317 C CA3118317 C CA 3118317C
Authority
CA
Canada
Prior art keywords
hydroxybutyrate
beta
approximately
composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3118317A
Other languages
English (en)
Other versions
CA3118317A1 (fr
Inventor
Ryan Lowery
Jacob Wilson
Terry LaCore
Original Assignee
Axcess Global Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcess Global Sciences LLC filed Critical Axcess Global Sciences LLC
Priority claimed from PCT/US2019/058676 external-priority patent/WO2020092451A1/fr
Publication of CA3118317A1 publication Critical patent/CA3118317A1/fr
Application granted granted Critical
Publication of CA3118317C publication Critical patent/CA3118317C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Dans divers modes de réalisation, le cannabidiol, le bêta-hydroxybutyrate, les composés apparentés et/ou un ou plusieurs autres composés peuvent être administrés à un individu pour améliorer la santé de l'individu. D'autres composés peuvent comprendre des acides aminés, des acides gras à chaînes courtes, des triglycérides à chaînes courtes, des acides gras à chaînes moyennes, des triglycérides à chaînes moyennes, des acides gras à longues chaînes, des triglycérides à longues chaînes, de la berbérine, des métabolites de la berbérine (par exemple la dihydroberbérine) et/ou des combinaisons de ceux-ci.
CA3118317A 2018-10-29 2019-10-29 Administration a l'homme de butyrate, de beta-hydroxybutyrate, de cannabidiol et de composes apparentes Active CA3118317C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862752170P 2018-10-29 2018-10-29
US62/752,170 2018-10-29
PCT/US2019/058676 WO2020092451A1 (fr) 2018-10-29 2019-10-29 Administration à l'homme de butyrate, de bêta-hydroxybutyrate, de cannabidiol et de composés apparentés
US16/667,851 2019-10-29
US16/667,851 US20200129463A1 (en) 2018-10-29 2019-10-29 Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans

Publications (2)

Publication Number Publication Date
CA3118317A1 CA3118317A1 (fr) 2020-05-07
CA3118317C true CA3118317C (fr) 2025-11-25

Family

ID=

Similar Documents

Publication Publication Date Title
AU2023219852B2 (en) Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
EP3873442B1 (fr) Composition pour la perte de poids ou la gestion du poids comprenant du bêta-hydroxybutyrate et du cannabidiol
US11969411B2 (en) Administration of berberine metabolites
US12109182B2 (en) Administration of R-beta-hydroxybutyrate and related compounds in humans
US20250302782A1 (en) Administration of beta-hydroxybutyrate and related compounds in humans for the treatment and/or prevention of respiratory illnesses
WO2023081409A1 (fr) Administration de métabolites de berbérine
WO2023278881A1 (fr) Administration de r-bêta-hydroxybutyrate et de composés apparentés chez l'être humain
US12171735B2 (en) Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
CA3118317C (fr) Administration a l'homme de butyrate, de beta-hydroxybutyrate, de cannabidiol et de composes apparentes
US20220339142A1 (en) Administration of r-beta-hydroxybutyrate salt blend and related compounds in humans
US20250332128A1 (en) Compositions and compounds containng ketone bodies and/or ketone body precursors and one or more amino acids
US20220202789A1 (en) Administration of berberine metabolites
WO2023212319A1 (fr) Administration d'un mélange de sels de r-bêta-hydroxybutyrate et de composés apparentés chez l'homme